CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 952645573
- Phone
- 9493792875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- Open-market buys, last 90 days
- $158,000
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$158,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-13 | Kenny John P. Director | Grant or award · Non-qualified stock option | +75,000 | 75,000 | ||
| 2023-12-13 | MOATAZEDI DAVID Director | Grant or award · Non-qualified stock option | +75,000 | 75,000 | ||
| 2023-12-13 | Coste Catherine Director | Grant or award · Non-qualified stock option | +75,000 | 75,000 | ||
| 2023-12-13 | BARBIERI ALLEN Executive Vice Chairman | Grant or award · Non-qualified stock option | +100,000 | 100,000 | ||
| 2023-08-29 | Kenny John P. Director | Grant or award · Non-qualified stock option | +30,000 | 30,000 | ||
| 2023-05-25 | Irani Zackary S. Chief Executive Officer | Purchase | +200 | $1.55 | $310 | 1,020,560 |
| 2023-05-24 | Irani Zackary S. Chief Executive Officer | Purchase | +500 | $1.61 | $805 | 1,020,360 |
| 2023-05-12 | Irani Zackary S. Chief Executive Officer | Purchase | +1,700 | $1.17 | $2K | 1,019,860 |
| 2023-05-10 | Irani Zackary S. Chief Executive Officer | Purchase | +500 | $1.27 | $635 | 1,018,160 |
| 2023-05-09 | Irani Zackary S. Chief Executive Officer | Purchase | +300 | $1.39 | $417 | 1,017,660 |
| 2023-05-04 | Irani Zackary S. Chief Executive Officer | Purchase | +1,000 | $1.36 | $1K | 1,017,360 |
| 2023-04-28 | Irani Zackary S. Chief Executive Officer | Purchase | +1,800 | $1.34 | $2K | 1,017,360 |
| 2023-04-27 | Irani Zackary S. Chief Executive Officer | Purchase | +2,600 | $1.31 | $3K | 1,017,360 |
| 2023-04-26 | Irani Zackary S. Chief Executive Officer | Purchase | +7,000 | $1.26 | $9K | 1,012,960 |
| 2023-04-20 | MOATAZEDI DAVID Director | Grant or award · Non-qualified stock option | +25,000 | 25,000 | ||
| 2023-04-20 | MOATAZEDI DAVID Director | Grant or award · Non-qualified stock option | +32,000 | 32,000 | ||
| 2023-04-20 | Irani Zackary S. Chief Executive Officer | Grant or award · Non-qualified stock option | +105,000 | 105,000 | ||
| 2023-04-20 | BARBIERI ALLEN Vice Chairman | Grant or award · Non-qualified stock option | +50,000 | 50,000 | ||
| 2023-04-20 | Emerson Jane Director | Grant or award · Non-qualified stock option | +32,000 | 32,000 | ||
| 2023-04-20 | Coste Catherine Director | Grant or award · Non-qualified stock option | +32,000 | 32,000 |
Page 2 of 16 · 303 trades